Edition:
United Kingdom

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

10.65USD
4:56pm GMT
Change (% chg)

$-0.10 (-0.93%)
Prev Close
$10.75
Open
$10.80
Day's High
$10.80
Day's Low
$10.54
Volume
85,279
Avg. Vol
175,304
52-wk High
$34.50
52-wk Low
$9.38

Chart for

About

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as well as to develop cancer therapeutics against difficult-to-drug targets. Its pipeline is focused on the development... (more)

Overall

Beta: --
Market Cap(Mil.): $792.65
Shares Outstanding(Mil.): 36.87
Dividend: --
Yield (%): --

Financials

  CTMX.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -1.70 -- --
ROI: -26.13 8.89 13.82
ROE: -81.04 10.00 15.25

Earnings vs. Estimates